Shanqiang Qu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Transcription Factor

Major Depressive Disorder

High Throughput

Top Venues

Molecular biomedicine

Cancer innovation

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Shanqiang Qu, Rongyang Xu, Guozhong Yi, Zhiyong Li, Huayang Zhang, Song-Tao Qi, Guang-Long Huang
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Molecular biomedicine 5 (1) (2024)
Shanqiang Qu, Rongyang Xu, Guozhong Yi, Zhiyong Li, Huayang Zhang, Song-Tao Qi, Guang-Long Huang
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Molecular biomedicine 5 (1) (2024)
Shanqiang Qu, Rongyang Xu, Guozhong Yi, Zhiyong Li, Huayang Zhang, Song-Tao Qi, Guang-Long Huang
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Molecular biomedicine 5 (1) (2024)
Shanqiang Qu, Rongyang Xu, Guozhong Yi, Zhiyong Li, Huayang Zhang, Song-Tao Qi, Guang-Long Huang
Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Molecular biomedicine 5 (1) (2024)
Luyao Wang, Rongyang Xu, Chengying Huang, Guozhong Yi, Zhiyong Li, Huayang Zhang, Rongxu Ye, Songtao Qi, Guanglong Huang, Shanqiang Qu
Targeting the ferroptosis crosstalk: novel alternative strategies for the treatment of major depressive disorder. General psychiatry 36 (5) (2023)
Rongyang Xu, Luyao Wang, Shanqiang Qu
A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers. Molecular biomedicine 4 (1) (2023)
Luyao Wang, Rongyang Xu, Chengying Huang, Shanqiang Qu
The antiferroptotic role of TRIM7: Molecular mechanism and synergistic effect with temozolomide. Cancer innovation 2 (4) (2023)
Chengying Huang, Ouwen Qiu, Chaofu Mao, Zhicheng Hu, Shanqiang Qu
An integrated analysis of C5AR2 related to malignant properties and immune infiltration of gliomas. Cancer innovation 1 (3) (2022)
Chaofu Mao, Chengying Huang, Zhicheng Hu, Shanqiang Qu
Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells. MedComm 3 (4) (2022)
Shanqiang Qu, Tianyu Hu, Ouwen Qiu, Yuejiao Su, Jiayu Gu, Zhibo Xia
Effect of Piezo1 Overexpression on Peritumoral Brain Edema in Glioblastomas. AJNR. American journal of neuroradiology 41 (8) (2020)
Shanqiang Qu, Zhixin Chen, Bin Liu, Jin Liu, Huafu Wang
N6-methyladenine-related genes affect biological behavior and the prognosis of glioma. Cancer medicine 10 (1) (2020)
Shanqiang Qu, Shuting Li, Zhicheng Hu
Upregulation of Piezo1 Is a Novel Prognostic Indicator in Glioma Patients. Cancer management and research 12 (2020)